CL2008001073A1 - Uso de una secuencia de acido nucleico que codifica para un homologo tdr4 para obtener un tejido vegetal con contenido alterado de un componente flavonoide. - Google Patents

Uso de una secuencia de acido nucleico que codifica para un homologo tdr4 para obtener un tejido vegetal con contenido alterado de un componente flavonoide.

Info

Publication number
CL2008001073A1
CL2008001073A1 CL2008001073A CL2008001073A CL2008001073A1 CL 2008001073 A1 CL2008001073 A1 CL 2008001073A1 CL 2008001073 A CL2008001073 A CL 2008001073A CL 2008001073 A CL2008001073 A CL 2008001073A CL 2008001073 A1 CL2008001073 A1 CL 2008001073A1
Authority
CL
Chile
Prior art keywords
tdr4
homolog
nucleic acid
acid sequence
sequence encoding
Prior art date
Application number
CL2008001073A
Other languages
English (en)
Inventor
Mervin Cecil Poole
Graham Barron Seymour
Helen Elizabeth Cameron Thomson
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of CL2008001073A1 publication Critical patent/CL2008001073A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8214—Plastid transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/825—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving pigment biosynthesis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8251—Amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis

Abstract

Uso de una secuencia de ácido nucleico que codifica para un homólogo tdr4 para obtener un tejido vegetal con contenido alterado, preferiblemente aumentado de un componente flavonoide.
CL2008001073A 2007-04-16 2008-04-15 Uso de una secuencia de acido nucleico que codifica para un homologo tdr4 para obtener un tejido vegetal con contenido alterado de un componente flavonoide. CL2008001073A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07106246 2007-04-16

Publications (1)

Publication Number Publication Date
CL2008001073A1 true CL2008001073A1 (es) 2009-01-16

Family

ID=38477341

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008001073A CL2008001073A1 (es) 2007-04-16 2008-04-15 Uso de una secuencia de acido nucleico que codifica para un homologo tdr4 para obtener un tejido vegetal con contenido alterado de un componente flavonoide.

Country Status (3)

Country Link
AR (1) AR066068A1 (es)
CL (1) CL2008001073A1 (es)
WO (1) WO2008125433A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120123064A (ko) * 2009-12-28 2012-11-07 페이수 링 해바라기 추출물을 포함한 약학 조성물, 그의 제조 방법 및 용도
CN105900835A (zh) * 2016-04-14 2016-08-31 贵州省亚热带作物研究所 一种火龙果花药诱导胚性愈伤组织的方法
CN109699498B (zh) * 2019-03-11 2021-09-03 成都大学 一种杜鹃兰愈伤组织的培养方法
CN110951763B (zh) * 2019-11-25 2021-11-30 中国热带农业科学院热带生物技术研究所 一种马铃薯y病毒属病毒诱导的基因沉默系统及其应用
CN112931222A (zh) * 2021-04-14 2021-06-11 苏州回文生物种业科技有限公司 一种柘木组培苗继代培养方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030041356A1 (en) * 2001-03-27 2003-02-27 Lynne Reuber Methods for modifying flowering phenotypes
WO2001004315A2 (en) * 1999-07-12 2001-01-18 The Texas A & M University System Ringene compositions and methods for use thereof
ES2380017T3 (es) * 2002-09-18 2012-05-07 Mendel Biotechnology, Inc. Polinucleótidos y polipéptidos en plantas
EP1928226B1 (en) * 2005-08-31 2011-10-19 Mendel Biotechnology, Inc. Stress tolerance in plants

Also Published As

Publication number Publication date
AR066068A1 (es) 2009-07-22
WO2008125433A1 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
AR092487A2 (es) Anticuerpos contra la angiopoyetina 2 humana
CL2012000258A1 (es) Proceso para la preparacion de composicion de aglomerante hidraulico asperjable que contiene como principales componentes agua, agregados, aglomerante hidraulico, acelerador de fraguado, aglomerante hidraulico asperjable; composicion; y uso
BRPI0921995A2 (pt) processo de deslocamento de gás para água , e, uso de um adsorvente.
GT201400136A (es) Compuestos y métodos de benzaldehído substituído para su uso en incrementar la oxigenación de los tejidos
CR11746A (es) Derivados de acido ciclopentanocarboxilico condensados sustituidos con acilamino y su uso como productos farmaceuticos
CO6300844A2 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa
CR11731A (es) Composiciones y procedimientos para su preparación y uso
CL2011002041A1 (es) Compuestos derivaados de 4-isopropilfenilglucitol, inhibidores de sglt1; preparacion farmaceutica; y su uso como agente para mejorar la hiperglucemia posprandial y como agente profilactico o terapeutico para la diabetes.
BRPI0921802A8 (pt) uso de um inibidor de fosfatidilinositol-3-cinase (pi3k) e um inibidor de mtor,bem como composição e combinação farmacêuticas os compreendendo.
CR20120011A (es) Inhibidores de bace
CO6720961A2 (es) Imidazopiridazinas sustituidas
BRPI1009981A2 (pt) sistemas , métodos e composições para otimizar os enxertos enriquecidos de tecido e célula
BRPI1010775A2 (pt) composição, método para preparar uma composição, e, uso de uma composição.
HN2010000084A (es) Derivados de sulfonamida
BRPI1011886A2 (pt) solução contendo ácido hiplocloroso e métodos do uso do mesmo.
CL2012000921A1 (es) Compuestos derivados de espiropiperidina-metilbenciloxifenil, activadores del receptor rpg-40; composicion farmaceutica que los comprende; y uso del compuesto para tratar diabetes.
CL2012000590A1 (es) Proceso para preparar w-transaminasa (r)-selectiva.
CL2007002971A1 (es) Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras.
CL2013002123A1 (es) Composicion herbicida que comprende topramezona y pinoxaden; uso de dicha composicion para controlar vegetación indeseable; formulación indeseable.
CL2008002537A1 (es) Compuestos derivados de acido 6-fenil-nicotinico, con actividad moduladora de ppar-alfa; procedimiento de preparacion; composicion farmaceutica que los comprende; y su uso para tratar y/o prevenir dislipidemias, arteriosclerosis e insuficiencia cardiaca.
BR112012032008A2 (pt) anticorpos s100a4 e usos terapêuticos do mesmo
CL2009001298A1 (es) Compuestos derivados de n-ciclohexil-2-fenoxinicotinamida; composición farmcéutica que los comprende; combinación farmacéutica que los comprende; y su uso para tratar una enfermedad mediada por la pde4.
CL2012003487A1 (es) Composicion farmaceutica oral que comprende un compuesto derivado de quinqzolina y acido alginico o sio2 como aditivo acidico.
BRPI0923291A2 (pt) processo para a destilação de uma mistura aquosa de polimetilol, composição, e, uso de um polimetilol.
CL2013000734A1 (es) Uso de una composicion que comprende compuestos derivados de 1-h-imidazol-4-il sustituido para bajar la presion intraocular; kit farmaceutico.